<DOC>
	<DOCNO>NCT00918411</DOCNO>
	<brief_summary>The purpose study explore examine endpoint allow evaluation `` clinically significant improvement , focus patient 's chief complaint severity major IBS symptom '' drug patient diarrhea-predominant irritable bowel syndrome ( IBS ) .</brief_summary>
	<brief_title>A Preliminary Study Explore Clinical Endpoints Patients ( Male ) With Diarrhea-predominant Irritable Bowel Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Diarrhea</mesh_term>
	<mesh_term>Irritable Bowel Syndrome</mesh_term>
	<mesh_term>Ramosetron</mesh_term>
	<criteria>Patients meet Rome III Diagnostic Criteria Loose ( mushy ) watery stool within last 3 month Patients hyperthyroidism hypothyroidism</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>diarrhea</keyword>
	<keyword>IBS</keyword>
	<keyword>Colonic disease</keyword>
	<keyword>YM060</keyword>
</DOC>